Intellipharmaceutics International Inc. (IPCIQ)

Market Cap	n/a
Revenue (ttm)	904.95K
Net Income (ttm)	-3.17M
Shares Out	n/a
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	396,750
Average Volume	32,168
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.1500
Beta	n/a
RSI	42.33
Earnings Date	Feb 28, 2025

About IPCIQ

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 11
• Stock Exchange: OTCMKTS
• Ticker Symbol: IPCIQ